Biosite(R) Incorporated Reports New Option Grants Under NASDAQ Market Rule 4350

SAN DIEGO, Aug. 15  /PRNewswire-FirstCall/ -- Biosite Incorporated (NASDAQ:BSTE), today announced that, in accordance with NASDAQ Marketplace Rule 4350, 19 non-officer employees were granted inducement stock options covering an aggregate of 37,825 shares of common stock.  These options were granted pursuant to NASDAQ Marketplace Rule 4350 (i)(1)(A)(iv) with the following terms: each option has been classified as a non-qualified stock option, has an exercise price equal to the fair market value on the grant date, has a ten-year term, and vests in 16 equal quarterly installments over four years (on each quarterly anniversary of the applicable vesting commencement date).

About Biosite Incorporated

Biosite Incorporated is a leading bio-medical company commercializing proteomics discoveries for the advancement of medical diagnosis.  The Company's products contribute to improvements in medical care by aiding physicians in the diagnosis of critical diseases and health conditions. Biosite's Triage(R) rapid diagnostics are used in more than 50 percent of U.S. hospitals and in more than 50 international markets.  Information on Biosite can be found at http://www.biosite.com/.

Biosite(R) Triage(R) and New Dimensions in Diagnosis(R) are registered trademarks of Biosite Incorporated.  The Company's logo is a trademark of Biosite Incorporated. 

DATASOURCE: Biosite Incorporated



CONTACT:  Nadine Padilla, Vice President, Corporate & Investor Relations

of Biosite Incorporated, [phone], 



Web site:  http://www.biosite.com/ 



Company News On-Call:  http://www.prnewswire.com/comp/116737.html 

Copyright